Blueprint Medicines Corporation (0HOJ.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:05PM BST
| Previous close | 93.71 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 276 |
| Market cap | 53.114M |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -11.06 |
| Earnings date | 31 July 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Thomson Reuters StreetEvents
Q1 2024 Blueprint Medicines Corp Earnings Call
Q1 2024 Blueprint Medicines Corp Earnings Call
- GuruFocus.com
Blueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises ...
Detailed Analysis of Financial Performance and Strategic Updates
ZacksBlueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates
Blueprint Medicines (BPMC) delivered earnings and revenue surprises of 19.51% and 16.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.